Probing the Osteoinductive Effect of Calcium Phosphate by Using an In Vitro Biomimetic Model
- 1 April 2011
- journal article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part A
- Vol. 17 (7-8), 1083-1097
- https://doi.org/10.1089/ten.tea.2010.0160
Abstract
The use of calcium phosphate (CaP)-based carriers in bone engineering is a promising approach to induce in vivo bone formation. However, the exact mechanism of osteoinduction by CaP is not known. Here, by mimicking the in vivo Ca(2+) and P(i)-enriched environment in an in vitro model, we assessed the effects of these ions on human periosteum-derived cells. We observed a significant Ca(2+) and P(i)-induced cell proliferation, which was found to be through the modulation of cell cycle progression, in a dose- and time-dependent manner. In addition, Ca(2+), P(i), and combined Ca-P upregulated osteogenic gene expression in a dose- and time-dependent manner. Encouragingly, both ions administered individually or in combination persistently and dose dependently upregulated bone morphogenetic protein-2 gene expression. This suggested a potential osteoinductive effect through an autonomous activation of the bone morphogenetic protein signaling pathway by released Ca(2+) and P(i), which may serve as an autocrine/paracrine osteoinduction loop that drives the cellularized CaP constructs toward effective bone formation in vivo. In conclusion, through an in vitro biomimetic model, we have partially probed the roles of the released Ca(2+) and P(i) on the osteoinductivity of CaP-based biomaterials.status: publisheKeywords
This publication has 75 references indexed in Scilit:
- 3D environment on human mesenchymal stem cells differentiation for bone tissue engineeringJournal of Materials Science: Materials in Medicine, 2009
- Dose-Dependent Osteogenic Effect of Octacalcium Phosphate on Mouse Bone Marrow Stromal CellsTissue Engineering, Part A, 2008
- Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuseBone, 2008
- EP4 agonist accelerates osteoinduction and degradation of β‐tricalcium phosphate by stimulating osteoclastogenesisJournal of Biomedical Materials Research Part A, 2008
- Oncostatin‐M Enhances Osteoinduction in a Rabbit Critical Calvarial Defect ModelThe Laryngoscope, 2007
- BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONSAnz Journal of Surgery, 2007
- An EP2 receptor-selective prostaglandin E2agonist induces bone healingProceedings of the National Academy of Sciences of the United States of America, 2003
- Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the SpineSpine, 2002
- Bone Morphogenetic Protein-2Published by Ovid Technologies (Wolters Kluwer Health) ,1996
- Bone: Formation by AutoinductionScience, 1965